Hyderabad-based Hetero to manufacture Covid drugs

[ad_1] Hyderabad: In a development that will focus the capabilities of Hyderabad’s pharmaceutical firms, Hetero, based in the city, will manufacture Remdesivir, licensed to treat patients with severe Covid-19 disease, at its formulation facility in Hyderabad. The facility has been approved by regulatory authorities such as the USFDA and the …

Read More »